Literature DB >> 17625156

JAK V617F missense mutation is absent in pancreatic cancer.

H M Kocher, L Mears, N C Lea, K Raj, G J Mufti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17625156      PMCID： PMC1955495          DOI： 10.1136/gut.2006.117754

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  11 in total

1.  Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.

Authors:  Takayuki Toyonaga; Kenji Nakano; Masahiro Nagano; Gang Zhao; Koji Yamaguchi; Syoji Kuroki; Takashi Eguchi; Kazuo Chijiiwa; Masazumi Tsuneyoshi; Masao Tanaka
Journal:  Cancer Lett       Date:  2003-11-10       Impact factor: 8.679

2.  Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.

Authors:  Yajun Han; Hesham M Amin; Bevin Franko; Christine Frantz; Xinzhe Shi; Raymond Lai
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

Review 3.  The myeloproliferative disorders.

Authors:  Peter J Campbell; Anthony R Green
Journal:  N Engl J Med       Date:  2006-12-07       Impact factor: 91.245

4.  Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

Authors:  Hisanobu Ogata; Takashi Kobayashi; Takatoshi Chinen; Hiromi Takaki; Takahito Sanada; Yasumasa Minoda; Keiko Koga; Giichi Takaesu; Yoshihiko Maehara; Mitsuo Iida; Akihiko Yoshimura
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

5.  Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro.

Authors:  Chen Huang; Jun Cao; Ke J Huang; Fang Zhang; Tao Jiang; Lin Zhu; Zheng J Qiu
Journal:  Cancer Sci       Date:  2006-10-19       Impact factor: 6.716

6.  Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.

Authors:  Shaik Ohidar Rahaman; Michael A Vogelbaum; S Jaharul Haque
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.

Authors:  Kolaparthi Venkatasubbarao; Ahsan Choudary; James W Freeman
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

8.  JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.

Authors:  D P Steensma; R F McClure; J E Karp; A Tefferi; T L Lasho; H L Powell; G W DeWald; S H Kaufmann
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

9.  Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

Authors:  Arne Scholz; Sandra Heinze; Katharina M Detjen; Michael Peters; Martina Welzel; Peter Hauff; Michael Schirner; Bertram Wiedenmann; Stefan Rosewicz
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

10.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

Authors:  Linda M Scott; Wei Tong; Ross L Levine; Mike A Scott; Philip A Beer; Michael R Stratton; P Andrew Futreal; Wendy N Erber; Mary Frances McMullin; Claire N Harrison; Alan J Warren; D Gary Gilliland; Harvey F Lodish; Anthony R Green
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245
View more
  3 in total

Review 1.  Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.

Authors:  Ignacio Garrido-Laguna; Manuel Hidalgo
Journal:  Nat Rev Clin Oncol       Date:  2015-03-31       Impact factor: 66.675

2.  The two faces of Janus kinases and their respective STATs in mammary gland development and cancer.

Authors:  Kay-Uwe Wagner; Jeffrey W Schmidt
Journal:  J Carcinog       Date:  2011-12-08

3.  Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.

Authors:  Patricia Adamo; Caroline M Cowley; Christopher P Neal; Vilas Mistry; Karen Page; Ashley R Dennison; John Isherwood; Robert Hastings; JinLi Luo; David A Moore; Pringle J Howard; Martins L Miguel; Catrin Pritchard; Margaret Manson; Jacqui A Shaw
Journal:  Oncotarget       Date:  2017-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.